Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Common stock	Additional paid-in capital	Accumulated other comprehensive income (loss)	Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2022		107,673,052
Beginning balance at Dec. 31, 2022	$ 502,125	$ 108	$ 1,055,048	$ (9,557)	$ (543,474)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	35,811		35,811
Common stock issued under employee stock plans (in shares)		2,218,811
Common stock issued under employee stock plans	5,853	$ 2	5,851
Taxes paid related to net share settlement of equity awards	(16,864)		(16,864)
Repurchase of common stock (in shares)		(100,000)
Repurchase of common stock	(2,519)		(2,519)
Unrealized income (loss) on derivative instruments, net of tax	(4,980)			(4,980)
Unrealized income (loss) on available for sale securities, net of tax	156			156
Net loss	(38,304)				(38,304)
Ending balance (in shares) at Mar. 31, 2023		109,791,863
Ending balance at Mar. 31, 2023	481,278	$ 110	1,077,327	(14,381)	(581,778)
Beginning balance (in shares) at Dec. 31, 2023		109,103,721
Beginning balance at Dec. 31, 2023	489,648	$ 109	1,142,578	(8,649)	(644,390)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	32,093		32,093
Common stock issued under employee stock plans (in shares)		2,485,389
Common stock issued under employee stock plans	6,414	$ 3	6,411
Taxes paid related to net share settlement of equity awards	(34,860)		(34,860)
Unrealized income (loss) on derivative instruments, net of tax	1,797			1,797
Unrealized income (loss) on available for sale securities, net of tax	(2,253)			(2,253)
Net loss	(40,490)				(40,490)
Ending balance (in shares) at Mar. 31, 2024		111,589,110
Ending balance at Mar. 31, 2024	$ 452,349	$ 112	$ 1,146,222	$ (9,105)	$ (684,880)